ICICI Securities: Indian Pharma Market Growth Negative; Expect Strong FY22E

The Indian Pharma Market has reported yet another month of decline with 2.2% drop in sales, primarily driven by acute segments.

ICICI Securities

15 Sep 2020, 07:37 PM IST

An employee scoops up tablet cores for inspection at a pharmaceutical plant. (Photographer Hannelore Foerster/Bloomberg)

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

ICICI Securities: Indian Pharma Market Growth Negative; Expect Strong FY22E

The Indian Pharma Market has reported yet another month of decline with 2.2% drop in sales, primarily driven by acute segments.

Choose a plan